Researchers in the United States have developed an experimental chewing gum that may help reduce the spread of several viruses. The gum is designed to trap and neutralize viruses inside the mouth before they can infect human cells.
The innovation is still in the early research stage. However, initial laboratory results have raised interest in its potential as a preventive tool against respiratory and oral viral infections.
Experimental Chewing Gum Designed to Target Viruses
The study was conducted by scientists at a US university. It focuses on a chewing gum infused with plant-based antiviral proteins.
The gum includes a modified form of ACE2 protein. This acts as a decoy target for the virus responsible for COVID-19, known as SARS-CoV-2.
It also contains a bean-derived protein called FRIL. This protein can bind to influenza and herpes viruses, reducing their ability to spread.
Laboratory Results Show Promising Viral Reduction
In laboratory testing, the gum demonstrated strong antiviral activity. Small amounts of the gum reduced viral loads in saliva samples by more than 95% for certain viruses.
The mechanism works by “binding and neutralizing” virus particles in the mouth. This process may reduce transmission risk during close human contact.
Researchers believe this approach could be particularly useful in environments where viruses spread easily.
Potential Use in High-Risk Environments
Scientists suggest the gum could be beneficial in settings such as hospitals, schools, and crowded public spaces.
These environments often increase the risk of viral transmission due to close human interaction.
The gum is designed as a simple preventive tool. It may help reduce viral spread when used alongside existing health measures.
Still in Experimental Stage
Despite promising results, researchers emphasize that the product is not yet ready for public use.
Human clinical trials are still required to confirm safety and effectiveness. Laboratory success does not always translate directly into real-world results.
Experts stress that the gum is not a replacement for vaccines or medical treatments. It may only serve as a supplementary preventive measure in the future.
Future Possibilities in Viral Prevention
If further trials succeed, antiviral chewing gum could become a convenient tool for reducing virus transmission.
Its simple use makes it potentially suitable for mass adoption in public health strategies. However, more research is needed before approval or commercial availability.
For now, the concept remains experimental but represents an innovative step in antiviral research.
